Copyright
©The Author(s) 2022.
World J Clin Cases. Dec 16, 2022; 10(35): 13122-13128
Published online Dec 16, 2022. doi: 10.12998/wjcc.v10.i35.13122
Published online Dec 16, 2022. doi: 10.12998/wjcc.v10.i35.13122
Table 1 Baseline general information and clinical and laboratory characteristics
| Characteristics | ||
| Age | 77 | yr |
| Sex | Male | |
| Dry weight | 48.5 | kg |
| Blood pressure | 126/59 | mmHg |
| Dialysis method | Hemodialysis | |
| HGB | 68 | g/L |
| RBC | 2.13 | 1012/L |
| WBC | 5.56 | 109/L |
| Serum iron | 8.3 | µmol/L |
| FER | 588.7 | ng/mL |
| TSAT | 20.9 | % |
| K | 4.09 | mmol/L |
| PTH | 14.6 | ng/mL |
| Blood lipids | ||
| TG | 1.14 | mmol/L |
| TC | 3.99 | mmol/L |
| HDL-C | 0.84 | mmol/L |
| LDL-C | 2.49 | mmol/L |
- Citation: Xu C, Luo DG, Liu ZY, Yang D, Wang DD, Xu YZ, Yang J, Fu B, Qi AR. Response to roxadustat in a patient undergoing long-term dialysis and allergic to erythropoiesis-stimulating agents: A case report . World J Clin Cases 2022; 10(35): 13122-13128
- URL: https://www.wjgnet.com/2307-8960/full/v10/i35/13122.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i35.13122
